14 Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Xtant Medical Holdings Inc XTNT rose 20 percent to $1.35 in pre-market trading after the company issued strong revenue forecast for the third quarter.
• NQ Mobile Inc (ADR) NQ rose 10.4 percent to $4.35 in pre-market trading after gaining 0.25 percent on Monday.
• Lipocine Inc LPCN rose 6.3 percent to $5.89 in pre-market trading after gaining 2.40 percent on Monday.
• Merrimack Pharmaceuticals Inc MACK rose 6 percent to $6 in pre-market trading after the company reported that its Phase 3 NAPOLI-1 study confirmed overall survival and progression-free survival benefit of ONIVYDE for pancreatic cancer patients.
• JinkoSolar Holding Co., Ltd. JKS shares rose 4.2 percent to $17.49 in pre-market trading after the company announced a 300MW supply agreement with Senyuan Electric and agreed to sell downstream business in China for $250 million in cash.
• Radius Health Inc RDUS rose 3.7 percent to $54.00 in pre-market trading after gaining 0.97 percent on Monday.
• Seagate Technology PLC STX rose 2.2 percent to $38.80 in the pre-market trading after the company reported strong preliminary sales for the first quarter.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Illumina, Inc. ILMN shares fell 26.3 percent to $136.25 in pre-market trading after the company preannounced Q3 revenues short of estimates. The company’s Q4 revenue projection also came in short of estimates.
• Eleven Biotherapeutics Inc EBIO shares fell 8.8 percent to $2.18 in pre-market trading after climbing 10.65 percent on Monday.
• Lumentum Holdings Inc LITE fell 6 percent to $41.84 in pre-market trading. Goldman Sachs downgraded Lumentum from Neutral to Sell.
• IntelliPharmaCeutics Intl Inc (USA) IPCI shares fell 5 percent to $2.70 in pre-market trading after surging 19.33 percent on Monday.
• Alcoa Inc AA shares fell 4.6 percent to $30.07 in pre-market trading after the company reported Q3 results. Alcoa posted Q3 adjusted earnings of $0.32 per share on sales of $5.2 billion.
• Pacific Biosciences of California PACB fell 4.2 percent to $8.67 in pre-market trading following Illumina warning.
• St. Jude Medical, Inc. STJ shares fell 3.2 percent to $78.73 in pre-market trading after gaining 0.52 percent on Monday.